Heerlen, NL, 06 Nov 2013 16:15 CET
Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €300 million 1.75% bond due 2019.
The proceeds will be used to refinance the $150 million US Private Placement that matured in October 2013 and to refinance some short term commercial paper with a longer maturity.
The terms are laid down in the €4 billion Debt Issuance Program of Royal DSM, the final terms and the supplements thereto, which are available here.
The re-offer price was 99.96%. Based on this price the yield is 1.7570%. The bond will be listed on Euronext Amsterdam shortly.
This release does not constitute an offer or an invitation to subscribe for or purchase any securities. The notes are being offered only by means of a prospectus.